Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04421573 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cervical Plexus Hydrodissection With D5W for PTSD

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: 3 to 4v34
  2. Primary completion pushed from Oct 1, 2026 to Oct 1, 2027
    • Trial status changed: Recruiting → Active, Not Recruiting
    • Site details revised at 4 of 4 sites
    v33
  3. Secondary endpoints: 2 to 3
    • Study sites revised (4)
    • Eligibility criteria shortened, about 5 words
    v32
  4. Site contacts updated at 1 of 4 sitesv31
  5. Study sites revised (4)
    • Collaborators: 6 to 4
    v30
Show 28 earlier versionsHide 28 earlier versions
  1. Study sites: 5 to 4v29
  2. Study sites: 7 to 5
    • Collaborators: 7 to 6
    v28
  3. 2 versions Re-verified since Feb 4, 2025, no change to tracked fieldsv26-v27
  4. Study sites: 5 to 7
    • Collaborators: 5 to 7
    v25
  5. Publications: details revised at 1 of 1 entryv24
  6. Eligibility criteria expanded, about 4 wordsv23
  7. Study sites: 3 to 5
    • Collaborators: 4 to 5
    v22
  8. Re-verified, no change to tracked fieldsv21
  9. Primary endpoints: 2 to 3v20 Show 4 more changesShow less
    • Secondary endpoints revised (2)
    • Study description expanded, about 16 words
    • Study sites revised (3)
    • Collaborators: 3 to 4
  10. Re-verified, no change to tracked fieldsv19
  11. Site contacts updated at 1 of 3 sitesv18
  12. Eligibility criteria shortened, about 58 wordsv17
  13. Trial status: Withdrawn to Recruiting
    • Enrollment target: 0 to 24
    • Start date changed from estimate of Oct 1, 2023 to Jul 10, 2023
    • Site details revised at 3 of 3 sites
    v16
  14. Primary completion date: Mar 15, 2020 to Oct 1, 2026v15 Show 7 more changesShow less
    • Start date: Nov 1, 2019 to Oct 1, 2023
    • Study sites: 1 to 3
    • Study completion date: Mar 15, 2020 to Oct 1, 2027
    • Eligibility criteria expanded, about 105 words
    • Secondary endpoints: 6 to 2
    • Study description shortened, about 15 words
    • Collaborators expanded, about 9 words
  15. Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: Covid and lack of funding. See published case report. Another site is being sought.v14 Show 5 more changesShow less
    • Enrollment target: estimated 120 to confirmed 0
    • Primary completion date changed from estimate of Aug 1, 2028 to Mar 15, 2020
    • Study completion date changed from estimate of Aug 1, 2029 to Mar 15, 2020
    • Start date changed from estimate of Nov 1, 2021 to Nov 1, 2019
    • Site contact updated
  16. Primary completion date: Jun 7, 2027 to Aug 1, 2028v13 Show 4 more changesShow less
    • Start date: Jun 7, 2021 to Nov 1, 2021
    • Trial status: Recruiting to Not Yet Recruiting
    • Study completion date: Jun 7, 2028 to Aug 1, 2029
    • Site details revised
  17. Primary endpoints revised (2)
    • Secondary endpoints: 5 to 6
    v12
  18. Enrollment target: 20 to 120v11 Show 8 more changesShow less
    • Primary completion date: Jul 3, 2025 to Jun 7, 2027
    • Start date: Oct 6, 2020 to Jun 7, 2021
    • Primary endpoints: 3 to 2
    • Study completion date: Mar 3, 2026 to Jun 7, 2028
    • Interventions: Bilateral cervical plexus hydrodissetion with D5W (Procedure), Delayed/usual care treament (Procedure) to BCPHD with D5W (Procedure), Waiting period with usual care (Procedure)
    • Secondary endpoints: 4 to 5
    • Study description shortened, about 28 words
    • Study title shortened, about 7 words
  19. Primary completion date: Jul 3, 2021 to Jul 3, 2025v10 Show 6 more changesShow less
    • Start date: Jul 3, 2020 to Oct 6, 2020
    • Study completion date: Mar 3, 2024 to Mar 3, 2026
    • Interventions: Bilateral cervical plexus hydrodissetion with D5W (Procedure), Bilateral sternocleidomastoid muscle injection with D5W (Procedure) to Bilateral cervical plexus hydrodissetion with D5W (Procedure), Delayed/usual care treament (Procedure)
    • Secondary endpoints: 6 to 4
    • Study description revised
    • Eligibility criteria expanded, about 4 words
  20. Eligibility criteria revisedv9
  21. Study completion date: Mar 3, 2022 to Mar 3, 2024
    • Study description shortened, about 7 words
    v8
  22. Primary endpoints revised (3)v7 Show 4 more changesShow less
    • Eligibility criteria shortened, about 29 words
    • Secondary endpoints revised (6)
    • Study description shortened, about 49 words
    • Study title expanded, about 3 words
  23. Eligibility criteria shortened, about 4 wordsv6
  24. Enrollment target: 96 to 20
    • Study title expanded, about 3 words
    v5
  25. Secondary endpoints: 3 to 6v4
  26. Trial status: Not Yet Recruiting to Recruitingv3 Show 7 more changesShow less
    • Primary endpoints revised (3)
    • Primary completion date: Jul 1, 2021 to Jul 3, 2021
    • Study completion date: Jul 1, 2022 to Mar 3, 2022
    • Start date changed from estimate of Jul 1, 2020 to Jul 3, 2020
    • Secondary endpoints: 4 to 3
    • Site details revised
    • Eligibility criteria shortened, about 2 words
  27. Interventions: Bilateral hydrodissection of the cervical plexus (Procedure), Sham Procedure (Procedure) to Bilateral cervical plexus hydrodissetion with D5W (Procedure), Bilateral sternocleidomastoid muscle injection with D5W (Procedure)
    • Secondary endpoints: details revised at 1 of 4 entries
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Dr. Dean Reeves Clinic
5 trials monitored
See 1 trial at risk
PTSD
889 trials monitored
See 54 trials at risk
PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with a delayed/usual treatment control.
Trial Details
NCT Number NCT04421573
Lead Sponsor Dr. Dean Reeves Clinic
Collaborators: Paul Johnson, D.O., Eric Phillippi, M.D., Ryan Wood, N.D., Danesh Mazloomdoost
Conditions
(from sponsor)		 PTSD
Related terms Stress Disorders, Post-Traumatic
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov